These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 26255251

  • 1. C-terminal variable AGES domain of Thymosin β4: the molecule's primary contribution in support of post-ischemic cardiac function and repair.
    Hinkel R, Ball HL, DiMaio JM, Shrivastava S, Thatcher JE, Singh AN, Sun X, Faskerti G, Olson EN, Kupatt C, Bock-Marquette I.
    J Mol Cell Cardiol; 2015 Oct; 87():113-25. PubMed ID: 26255251
    [Abstract] [Full Text] [Related]

  • 2. Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction.
    Tan SH, Loo SJ, Gao Y, Tao ZH, Su LP, Wang CX, Zhang SL, Mu YH, Cui YH, Abdurrachim D, Wang WH, Lalic J, Lim KC, Bu J, Tan RS, Lee TH, Zhang J, Ye L.
    Theranostics; 2021 Oct; 11(16):7879-7895. PubMed ID: 34335970
    [Abstract] [Full Text] [Related]

  • 3. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.
    Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D.
    Nature; 2004 Nov 25; 432(7016):466-72. PubMed ID: 15565145
    [Abstract] [Full Text] [Related]

  • 4. Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection.
    Hinkel R, Trenkwalder T, Kupatt C.
    Ann N Y Acad Sci; 2012 Oct 25; 1269():102-9. PubMed ID: 23045977
    [Abstract] [Full Text] [Related]

  • 5. Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.
    Bock-Marquette I, Maar K, Maar S, Lippai B, Faskerti G, Gallyas F, Olson EN, Srivastava D.
    Int Immunopharmacol; 2023 Mar 25; 116():109741. PubMed ID: 36709593
    [Abstract] [Full Text] [Related]

  • 6. Thymosin β4-mediated protective effects in the heart.
    Hinkel R, Klett K, Bähr A, Kupatt C.
    Expert Opin Biol Ther; 2018 Jul 25; 18(sup1):121-129. PubMed ID: 30063857
    [Abstract] [Full Text] [Related]

  • 7. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo.
    Bock-Marquette I, Shrivastava S, Pipes GC, Thatcher JE, Blystone A, Shelton JM, Galindo CL, Melegh B, Srivastava D, Olson EN, DiMaio JM.
    J Mol Cell Cardiol; 2009 May 25; 46(5):728-38. PubMed ID: 19358334
    [Abstract] [Full Text] [Related]

  • 8. Thymosin beta4 is cardioprotective after myocardial infarction.
    Srivastava D, Saxena A, Michael Dimaio J, Bock-Marquette I.
    Ann N Y Acad Sci; 2007 Sep 25; 1112():161-70. PubMed ID: 17600280
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of adult resident cardiac progenitor cells by durable myocardial expression of thymosin beta 4 with ultrasound-targeted microbubble delivery.
    Chen S, Shimoda M, Chen J, Grayburn PA.
    Gene Ther; 2013 Feb 25; 20(2):225-33. PubMed ID: 23151517
    [Abstract] [Full Text] [Related]

  • 10. Thymosin beta4 and cardiac repair.
    Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I.
    Ann N Y Acad Sci; 2010 Apr 25; 1194():87-96. PubMed ID: 20536454
    [Abstract] [Full Text] [Related]

  • 11. Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner.
    Gladka MM, Kohela A, Molenaar B, Versteeg D, Kooijman L, Monshouwer-Kloots J, Kremer V, Vos HR, Huibers MMH, Haigh JJ, Huylebroeck D, Boon RA, Giacca M, van Rooij E.
    Nat Commun; 2021 Jan 04; 12(1):84. PubMed ID: 33398012
    [Abstract] [Full Text] [Related]

  • 12. Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model.
    Shah AP, Youngquist ST, McClung CD, Tzvetkova E, Hanif MA, Rosborough JP, Niemann JT.
    J Interferon Cytokine Res; 2011 Jun 04; 31(6):509-13. PubMed ID: 21332365
    [Abstract] [Full Text] [Related]

  • 13. Cardiac repair with thymosin β4 and cardiac reprogramming factors.
    Srivastava D, Ieda M, Fu J, Qian L.
    Ann N Y Acad Sci; 2012 Oct 04; 1270():66-72. PubMed ID: 23050819
    [Abstract] [Full Text] [Related]

  • 14. Thymosin beta4 regulates cardiac valve formation via endothelial-mesenchymal transformation in zebrafish embryos.
    Shin SH, Lee S, Bae JS, Jee JG, Cha HJ, Lee YM.
    Mol Cells; 2014 Apr 04; 37(4):330-6. PubMed ID: 24732964
    [Abstract] [Full Text] [Related]

  • 15. Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart.
    Smart N, Bollini S, Dubé KN, Vieira JM, Zhou B, Riegler J, Price AN, Lythgoe MF, Davidson S, Yellon D, Pu WT, Riley PR.
    Ann N Y Acad Sci; 2012 Oct 04; 1269():92-101. PubMed ID: 23045976
    [Abstract] [Full Text] [Related]

  • 16. Regulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart.
    Yan B, Singla RD, Abdelli LS, Singal PK, Singla DK.
    PLoS One; 2013 Oct 04; 8(9):e75580. PubMed ID: 24086577
    [Abstract] [Full Text] [Related]

  • 17. Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia.
    Hinkel R, Bock-Marquette I, Hatzopoulos AK, Kupatt C.
    Ann N Y Acad Sci; 2010 Apr 04; 1194():105-11. PubMed ID: 20536456
    [Abstract] [Full Text] [Related]

  • 18. Cardiac endothelial cells express Wilms' tumor-1: Wt1 expression in the developing, adult and infarcted heart.
    Duim SN, Kurakula K, Goumans MJ, Kruithof BP.
    J Mol Cell Cardiol; 2015 Apr 04; 81():127-35. PubMed ID: 25681586
    [Abstract] [Full Text] [Related]

  • 19. Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes.
    Zhou B, Honor LB, Ma Q, Oh JH, Lin RZ, Melero-Martin JM, von Gise A, Zhou P, Hu T, He L, Wu KH, Zhang H, Zhang Y, Pu WT.
    J Mol Cell Cardiol; 2012 Jan 04; 52(1):43-7. PubMed ID: 21907210
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic potential of thymosin-beta4 and its derivative N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) in cardiac healing after infarction.
    Cavasin MA.
    Am J Cardiovasc Drugs; 2006 Jan 04; 6(5):305-11. PubMed ID: 17083265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.